These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

527 related items for PubMed ID: 8820838

  • 1. Drugs or implantable cardioverter-defibrillators in patients with poor left ventricular function?
    Block M, Hammel D, Böcker D, Borggrefe M, Breithardt G.
    Am J Cardiol; 1996 Sep 12; 78(5A):62-8. PubMed ID: 8820838
    [Abstract] [Full Text] [Related]

  • 2. Risk stratification and clinical outcome of minimally symptomatic and asymptomatic patients with nonsustained ventricular tachycardia and coronary disease: a prospective single-center study.
    Giorgberidze I, Saksena S, Krol RB, Munsif AN, Kolettis T, Mathew P, Varanasi S, Prakash A, Delfaut P, Lewis CB.
    Am J Cardiol; 1997 Sep 11; 80(5B):3F-9F. PubMed ID: 9291444
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Drugs versus devices in controlling ventricular tachycardia, ventricular fibrillation, and recurrent cardiac arrest.
    Haverkamp W, Eckardt L, Borggrefe M, Breithardt G.
    Am J Cardiol; 1997 Oct 23; 80(8A):67G-73G. PubMed ID: 9354413
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Secondary prevention of sudden death: the Dutch Study, the Antiarrhythmics Versus Implantable Defibrillator Trial, the Cardiac Arrest Study Hamburg, and the Canadian Implantable Defibrillator Study.
    Cappato R.
    Am J Cardiol; 1999 Mar 11; 83(5B):68D-73D. PubMed ID: 10089843
    [Abstract] [Full Text] [Related]

  • 7. New primary prevention trials of sudden cardiac death in patients with left ventricular dysfunction: SCD-HEFT and MADIT-II.
    Klein H, Auricchio A, Reek S, Geller C.
    Am J Cardiol; 1999 Mar 11; 83(5B):91D-97D. PubMed ID: 10089848
    [Abstract] [Full Text] [Related]

  • 8. Antiarrhythmic drugs in patients with implantable cardioverter-defibrillators.
    Bollmann A, Husser D, Cannom DS.
    Am J Cardiovasc Drugs; 2005 Mar 11; 5(6):371-8. PubMed ID: 16259525
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Antiarrhythmic therapy in patients with heart failure].
    Faber TS, Zehender M.
    Ther Umsch; 2000 May 11; 57(5):324-32. PubMed ID: 10859993
    [Abstract] [Full Text] [Related]

  • 11. Influence of the implantable cardioverter/defibrillator on sudden death and total mortality in patients evaluated for cardiac transplantation.
    Sweeney MO, Ruskin JN, Garan H, McGovern BA, Guy ML, Torchiana DF, Vlahakes GJ, Newell JB, Semigran MJ, Dec GW.
    Circulation; 1995 Dec 01; 92(11):3273-81. PubMed ID: 7586314
    [Abstract] [Full Text] [Related]

  • 12. Antiarrhythmic drugs or implantable cardioverter defibrillators in heart failure: the "poor heart".
    Böcker D, Breithardt G.
    Am J Cardiol; 1999 Mar 11; 83(5B):83D-87D. PubMed ID: 10089846
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. [Pharmacologic therapy of ventricular tachyarrhythmias: value of class III anti-arrhythmia drugs].
    Haverkamp W, Borggrefe M, Block M, Böcker D, Breithardt G.
    Z Kardiol; 1996 Mar 11; 85 Suppl 6():97-106. PubMed ID: 9064989
    [Abstract] [Full Text] [Related]

  • 16. The Midlands Trial of Empirical Amiodarone versus Electrophysiology-guided Interventions and Implantable Cardioverter-defibrillators (MAVERIC): a multi-centre prospective randomised clinical trial on the secondary prevention of sudden cardiac death.
    Lau EW, Griffith MJ, Pathmanathan RK, Ng GA, Clune MM, Cooper J, Marshall HJ, Forsey PR, Stafford PJ, Gray RG, Skehan JD, Garratt CJ.
    Europace; 2004 Jul 11; 6(4):257-66. PubMed ID: 15172648
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effect of risk stratification on cost-effectiveness of the implantable cardioverter defibrillator.
    Owens DK, Sanders GD, Heidenreich PA, McDonald KM, Hlatky MA.
    Am Heart J; 2002 Sep 11; 144(3):440-8. PubMed ID: 12228780
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Therapeutic decision tree for patients with sustained ventricular tachyarrhythmias or aborted cardiac arrest: a critical review of the Antiarrhythmics Versus Implantable Defibrillator trial and the Canadian Implantable Defibrillator Study.
    Farré J, Cabrera JA, Romero J, Rubio JM.
    Am J Cardiol; 2000 Nov 02; 86(9A):44K-51K. PubMed ID: 11084100
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.